Monday, February 25, 2019

Support the Research Subject Bill of Rights

The new federal Right to Try law provides important protections to physicians and drug companies that help terminally-ill patients access investigational medications outside of clinical trials, but the rights of research subjects under the act are ambiguous. The Research Subject Bill of Rights is a set of state laws that clarify the rights of terminally-ill patients who are seeking access to treatments being studied in clinical trials.

Our model legislation gives terminally-ill patients the right to:
  • Access investigational treatments and drugs for off-label use without participating in randomized controlled clinical trials
  • Bypass clinical trial sponsors and manufacturers that refuse to provide access to treatment outside of their own clinical trials
  • Obtain insurance coverage for the direct costs of access to investigational treatments

Click here to read a draft of our bill. Comment below if you have any suggestions, questions, or concerns.